“…Kininogen: KLK1-(brady)kinin system (Marcondes and Antunes, 2005) (Brady)kinin receptor (BKR)2 (Biyashev et al, 2006) PAR1: PAR1-PKC-Src-MMP, keratinocyte migration; migration of prostate cancer cells (Gao et al, 2010a) (Gao et al, 2010b) BKR2, migration of circulating proangiogenic cells (Spinetti et al, 2011) KLK2 uPA (Frenette et al, 1997) KLK4 PAR1, PAR2, (Mize et al, 2008;Ramsay et al, 2008;Gratio et al, 2010) uPA-uPAR (Takayama et al, 2001Beaufort et al, 2006) PAR2 (Stefansson et al, 2008;Gratio et al, 2011;Chung et al, 2012) Brought to you by | University of California -San Francisco Authenticated Download Date | 11/19/14 9:11 AM In terms of the functional consequences of KLK activation of PARs, several studies have demonstrated that these mechanisms regulate important cellular responses in both physiological and pathological settings. For example, KLK1 promotes keratinocyte proliferation and migration in vitro and in an in vivo rat skin wound healing model via a PAR1 dependent, BKR2 independent mechanism requiring downstream activation of PKC and Src resulting in increased matrix metalloproteinase activity (MMP) and regulation of EGFR signalling (Gao et al, 2010a).…”